Results 31 to 40 of about 84,996 (200)

Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol [PDF]

open access: yes, 2021
BACKGROUND: Respiratory syncytial virus (RSV) infection is an important cause of hospitalization and death in young children. The majority of deaths (99%) occur in low- and lower-middle-income countries (LMICs).
RSV GOLD III—ICU Network study group
core  

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease

open access: yesDrug, Healthcare and Patient Safety, 2023
Shaun O’Hagan,1,2 Niamh Galway,3 Michael D Shields,3,4 Peter Mallett,1,4 Helen E Groves1,2 1Paediatric Infectious Diseases, Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland; 2Wellcome-Wolfson Institute for Experimental Medicine, Queen ...
O'Hagan S   +4 more
doaj  

Influence of age, severity of infection, and co-infection on the duration of respiratory syncytial virus (RSV) shedding [PDF]

open access: yes, 2015
RSV is the most important viral cause of pneumonia and bronchiolitis in children worldwide and has been associated with significant disease burden. With the renewed interest in RSV vaccines, we provide realistic estimates on duration, and influencing ...
Agoti, Charles N.   +7 more
core   +1 more source

A multifaceted approach to RSV vaccination

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Respiratory Syncytial Virus (RSV) is the leading cause of pneumonia and bronchiolitis in infants, resulting in significant morbidity and mortality worldwide.
Jorge C. G. Blanco   +3 more
doaj   +1 more source

Identification of group B respiratory syncytial viruses that lack the 60-nucleotide duplication after six consecutive epidemics of total BA dominance at coastal Kenya [PDF]

open access: yes, 2013
Respiratory syncytial virus BA genotype has reportedly replaced other group B genotypes worldwide. We report the observation of three group B viruses, all identical in G sequence but lacking the BA duplication, at a coastal district hospital in Kenya in ...
Agoti, Charles N.   +4 more
core   +1 more source

The ABCs of RSV

open access: yesThe Nurse Practitioner, 2018
Abstract: Respiratory syncytial virus (RSV) is a common viral infection affecting many children in the United States. This seasonal virus is the leading cause of hospitalization of infants and neonates. This article reviews the current recommendations for diagnostic testing, treatment options, and prevention of RSV.
openaire   +3 more sources

Serum RSV- and HPIV3-neutralizing antibody responses in hamsters following intranasal inoculation with rHPIV3-RSV-F vectors and wt RSV.

open access: yes, 2020
Additional hamsters in groups of 6 were inoculated as described in the legend to Fig 5 with the indicated HPIV3-RSV-F vectors, or the B/HPIV3 vector GS/DS-Cav1/B3TMCT, or wt RSV. (A, B) Serum RSV-neutralizing antibody titers.
Sonja Surman (185609)   +8 more
core   +1 more source

Non-Coding RNAs and Their Role in Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections

open access: yesViruses, 2020
Recent high-throughput sequencing revealed that only 2% of the transcribed human genome codes for proteins, while the majority of transcriptional products are non-coding RNAs (ncRNAs).
Wenzhe Wu   +4 more
doaj   +1 more source

microRNAs in viral acute respiratory infections: immune regulation, biomarkers, therapy, and vaccines [PDF]

open access: yesExRNA, 2019
MicroRNAs (miRNAs) are single-stranded RNAs of 17–24 nt. These molecules regulate gene expression at the post-transcriptional level and are differentially expressed in viral acute respiratory infections (ARIs), which are responsible for high morbidity ...
Stephen A. Leon-Icaza   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy